RAFAEL HOLDINGS, INC. Income (Loss) from Continuing Operations, Per Diluted Share
RAFAEL HOLDINGS, INC. (RFL) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$1.45 per share for the 12-month period ending 2024-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2024-04-30 was -$1.36.
- RAFAEL HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2024-01-31 was $0.25.
- RAFAEL HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2023-10-31 was -$1420.00.
- RAFAEL HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2023-04-30 was -$0.06.
- RAFAEL HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2024 was -$1.45.
- RAFAEL HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2023 was -$0.36.
- RAFAEL HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2022 was -$6.22.
- RAFAEL HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2021 was -$1.38.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|---|
| 2024-07-31 | -$1.45 10-K/A · filed 2024-12-20 | ||||
| 2024-04-30 | -$1.36 10-Q · filed 2024-06-14 | -$1.26 10-Q · filed 2024-06-14 | |||
| 2024-01-31 | $0.25 10-Q · filed 2024-03-14 | $0.10 10-Q · filed 2024-03-14 | |||
| 2023-10-31 | -$1420.00 10-Q · filed 2024-12-11 | -$0.16 10-Q · filed 2023-12-14 | |||
| 2023-07-31 | -$0.36 10-K/A · filed 2024-12-20 | ||||
| 2023-04-30 | -$0.06 10-Q · filed 2024-06-14 | -$0.42 10-Q · filed 2024-06-14 | |||
| 2023-01-31 | -$0.13 10-Q · filed 2024-03-14 | -$0.36 10-Q · filed 2024-03-14 | |||
| 2022-10-31 | -$0.22 10-Q · filed 2023-12-14 | ||||
| 2022-07-31 | -$6.22 10-K · filed 2023-10-30 | ||||
| 2022-04-30 | -$0.25 10-Q · filed 2023-06-13 | -$6.07 10-Q · filed 2023-06-13 | |||
| 2022-01-31 | -$0.09 10-Q · filed 2023-03-14 | -$5.86 10-Q · filed 2023-03-14 | |||
| 2021-10-31 | -$5.88 10-Q · filed 2022-12-13 | ||||
| 2021-07-31 | -$1.38 10-K · filed 2022-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |